Progressive brain dysfunction following intracerebroventricular infusion of beta1-42-amyloid peptide

被引:122
作者
Nakamura, S [1 ]
Murayama, N [1 ]
Noshita, T [1 ]
Annoura, H [1 ]
Ohno, T [1 ]
机构
[1] Suntory Biomed Res Ltd, Osaka 6188503, Japan
关键词
beta-amyloid protein; water maze task; spontaneous alternation performance; passive avoidance task; choline acetyltransferase; H-3]HC-3 binding; Alzheimer's disease;
D O I
10.1016/S0006-8993(01)02704-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The behavioral, neurochemical and histological changes of rats subjected to 3 days treatment with intracerebroventricular infusion of beta-amyloid peptides(A beta)((1-42)) were were investigated 20 days and 80 days after the surgery. A beta ((1-42)) produced a dose-dependent and a time-dependent impairment in the spontaneous alternation performance in the Y-maze (spatial working memory), place navigation task in a water maze (spatial reference memory) and passive avoidance retention (non-spatial long-term memory) at doses of 10 and 20 mug/rat. The learning impairments were more severe at 80 days than 20 days after infusion of A beta ((1-42)). At 25 days after the infusion, a significant decrease in hemicholinium-3 (HC-3) binding was observed only in the hippocampus, although choline acetyltransferase (ChAT) activity was unchanged in the brain regions tested as compared with the vehicle (A beta (40-1)) treatment. In contrast, the reduction in ChAT activity 85 days after A beta ((1-42)) infusion was significant in hippocampus and striatum. HC-3 binding was also significantly decreased in the posterior cortex, hippocampus and striatum. In the histological analysis, brain atrophy was observed inasmuch as ventricular enlargement and neuronal damage in the CA1 area of the hippocampus were seen 85 days after A beta ((1-42)) infusion. These results suggest that the rats subjected to intracerebroventricular infusion of A beta ((1-42)) suffered from progressive brain dysfunction, and could be useful as an animal model for evaluating the developmental processes at the early and/or middle stage of Alzheimer's-type dementia. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:128 / 136
页数:9
相关论文
共 36 条
[1]   β-amyloid peptides as direct cholinergic neuromodulators:: a missing link? [J].
Auld, DS ;
Kar, S ;
Quirion, R .
TRENDS IN NEUROSCIENCES, 1998, 21 (01) :43-49
[2]   The neurochemical and behavioral effects of beta-amyloid peptide(25-35) [J].
Chen, SY ;
Wright, JW ;
Barnes, CD .
BRAIN RESEARCH, 1996, 720 (1-2) :54-60
[3]   IMPLANTS CONTAINING BETA-AMYLOID PROTEIN ARE NOT NEUROTOXIC TO YOUNG AND OLD RAT-BRAIN [J].
CLEMENS, JA ;
STEPHENSON, DT .
NEUROBIOLOGY OF AGING, 1992, 13 (05) :581-586
[4]   A4 AMYLOID PROTEIN DEPOSITION AND THE DIAGNOSIS OF ALZHEIMERS-DISEASE - PREVALENCE IN AGED BRAINS DETERMINED BY IMMUNOCYTOCHEMISTRY COMPARED WITH CONVENTIONAL NEUROPATHOLOGIC TECHNIQUES [J].
DAVIES, L ;
WOLSKA, B ;
HILBICH, C ;
MULTHAUP, G ;
MARTINS, R ;
SIMMS, G ;
BEYREUTHER, K ;
MASTERS, CL .
NEUROLOGY, 1988, 38 (11) :1688-1693
[5]  
DAVIES P, 1976, LANCET, V2, P1403
[6]   THE ACUTE NEUROTOXICITY AND EFFECTS UPON CHOLINERGIC AXONS OF INTRACEREBRALLY INJECTED BETA-AMYLOID IN THE RAT-BRAIN [J].
EMRE, M ;
GEULA, C ;
RANSIL, BJ ;
MESULAM, MM .
NEUROBIOLOGY OF AGING, 1992, 13 (05) :553-559
[7]   RAPID RADIOCHEMICAL METHOD FOR DETERMINATION OF CHOLINE-ACETYLTRANSFERASE [J].
FONNUM, F .
JOURNAL OF NEUROCHEMISTRY, 1975, 24 (02) :407-409
[8]   LACK OF ALZHEIMER PATHOLOGY AFTER BETA-AMYLOID PROTEIN INJECTIONS IN RAT-BRAIN [J].
GAMES, D ;
KHAN, KM ;
SORIANO, FG ;
KEIM, PS ;
DAVIS, DL ;
BRYANT, K ;
LIEBERBURG, I .
NEUROBIOLOGY OF AGING, 1992, 13 (05) :569-576
[9]   Long-term changes in the aggregation state and toxic effects of β-amyloid injected into the rat brain [J].
Giovannelli, L ;
Scali, C ;
Faussone-Pellegrini, MS ;
Pepeu, G ;
Casamenti, F .
NEUROSCIENCE, 1998, 87 (02) :349-357
[10]   DIFFERENTIAL-EFFECTS OF AMYLOID PEPTIDES BETA-(1-40) AND BETA-(25-35) INJECTIONS INTO THE RAT NUCLEUS BASALIS [J].
GIOVANNELLI, L ;
CASAMENTI, F ;
SCALI, C ;
BARTOLINI, L ;
PEPEU, G .
NEUROSCIENCE, 1995, 66 (04) :781-792